All Change For BIA Board
This article was originally published in Scrip
The UK BioIndustry Association (BIA) has named Dr. Jane Osbourn – current vice-president of research and development at MedImmune LLC (an AstraZeneca plc company) – its new chair, effective January 2016. Osbourn has over 25 years of experience in the life science sector, initially as an academic before moving into biotech with Cambridge Antibody Technology in 1993. Osbourn received her Ph.D. from the John Innes Centre for Plant Science Research in Norwich. She succeeds Dr. Edward Hodgkin, CEO of Autolus, who is standing down as chair of the board but will remain a director.
You may also be interested in...
Diversity in all forms is critical to innovation in health care, says AstraZeneca’s chief medical officer, Ann Taylor. In an exclusive interview, she talks about the company’s work in mentoring and education, and why tackling issues around diversity and inclusion must be driven by the C-suite alongside community initiatives.
A selection of articles you might have missed from October 2020, including exclusive interviews with industry leaders and a deeper dive into the Femtech market.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.